Sentences with phrase «tumor at diagnosis»

Prognosis for mammary gland carcinomas depends on the size of the tumor at diagnosis as well as the biopsy results or tumor grade.

Not exact matches

They analyzed patient factors such as age, stage at diagnosis, histologic type, Breslow thickness (a measurement of how deep the tumor is), and ulceration.

To illustrate that point, they analyzed a series of 95 patients with a confirmed diagnosis of brain tumor at their department.

Prostate cancer risk groups are assigned based on the prostate biopsy results, which include the Gleason score (GS)-- an indication of how aggressively the tumor cells may behave — and the prostate specific antigen (PSA) level in the patient's blood at the time of diagnosis.

The authors conclude, «Unvalidated guidelines to prevent neuroimaging in patients with headaches may reduce the perceived global economic burden at the expense of medical errors, delayed diagnoses, and inferior outcomes for patients with brain tumor.»

Then again, the Web is also making us sicker, or at least making us feel that way: A 2008 study by Microsoft Research showed that Internet searchers tend to focus on only the top few results, typically highlighting rarer, more serious diagnoses of common ailments such as headache (brain tumor!)

Outcomes were excellent irrespective of patient age at diagnosis, tumor size, and tumor grade.

Principal Investigator John Morris, MD, clinical co-leader of the Molecular Therapeutics and Diagnosis Program for the CCC, co-leader of the UC Cancer Institute's Comprehensive Lung Cancer Program, professor in the division of hematology oncology at the UC College of Medicine and UC Health medical oncologist, says a number of antitumor vaccines have shown promise for causing immune responses against tumor antigens to improve patient outcomes.

Unfortunately, approximately 85 percent of cancer patients are ineligible for surgery at the time of diagnosis, either because the tumor is entwined in critical vasculature or the disease has progressed too far.

«These findings raise the possibility that by determining the gene expression profile of a patient's tumor, physicians may be able to identify aggressive disease at the outset of diagnosis and start treatment earlier,» said Sungyong You, PhD, an instructor in the Cedars - Sinai Department of Surgery and the first author of the study.

Indeed, as he and his colleagues went on to report, the 217 microRNAs that had been identified to date could be more effective at classifying tumors than the 20,000 protein - coding RNAs already used for diagnosis.

In order to enhance the diagnosis of CNS tumors, a team led by Professor Stefan Pfister, KiTZ director and department head of «Pediatric Neurooncology» at the DKFZ, in collaboration with colleagues from the Neuropathology Department at Heidelberg University Hospital led by Professor Andreas von Deimling, have developed a new computer - based method.

Pooled data show PET imaging of metabolic tumor burden at diagnosis helps identify patients most at risk of FL recurrence.

While a portion of her tumor cells went to a lab for diagnosis, another was sent, without her authorization, to researchers at Johns Hopkins University Medical School [source: Highfield].

Research in the Immunology, Microenvironment and Metastasis program is aimed at 1) merging basic mechanistic understanding of multidisciplinary pathways of host - tumor interactions and metastatic dissemination with novel translational opportunities for diseases diagnosis and immunotherapy, as well as 2) investigating mechanisms regulating immune responses in cancer and their potential therapeutic manipulation.

Added co-author Richard K. Wilson, Ph.D., director of The Genome Institute at Washington University School of Medicine in St. Louis: «We've made some very exciting discoveries that likely will result in more effective diagnosis and treatment of these particularly nasty tumors.»

All tumor samples were obtained at initial diagnosis via the Children's Oncology Group (COG) trials.

Positron emission tomography (PET) imaging of metabolic tumor burden at diagnosis and after induction therapy can help identify patients most at risk of follicular lymphoma (FL) recurrence, but more work is needed to differentiate high - risk and moderate - risk patients, suggested findings from a pooled analysis of data from three prospective clinical trials, published in Blood.

Panels run at the time of diagnosis identify both clinically - actionable driver mutations associated with the primary tumor, as well as the subclonal architecture that may be present.

He is also the author of 12 patents for the preparation of aqueous suspensions at high concentration of particulate, for the therapy and photodynamic diagnosis of tumors, for the conservation of the cultural heritage, for the setup of a new process for the treatment of textile industrial waste, for production of emulsions from Bio Crude Oil, for production of nanoparticles and novel nano - coatings via flame - spraying, and using homogeneous and heterogeneous solutions.

At The University of Michigan, our Cranial Base Program diagnoses and treats benign and malignant tumors involving the cranial base region, cerebrospinal fluid leaks and encephaloceles, and traumatic injuries to the face and skull.

Through her own diagnosis of a neuroendocrine tumor at the age of 18, Bailey developed a passion to become a nurse and an interest in Functional Medicine.

The tumors are very aggressive and metastatic, so it is a fair assumption that at the time of diagnosis the disease will have already spread beyond the primary site.

In order to help determine whether or not a malignant mammary tumor has spread to other tissues at the time of diagnosis, chest and abdominal x-rays, and abdominal ultrasound are recommended.

Evidence - Based Review of Surgical Treatment for Canine Cranial Cruciate Ligament Rupture Beyond Culture: Unraveling the Role of Bacteria in Gastrointestinal Disease Feline Pancreatitis Understanding Intestinal Microbiota - A Role for Probiotics Repair of Oro - Nasal Fistulae Canine Mast Cell Tumors Feline IBD (Inflammatory Bowel Disease): Diets, Bacteria, Diagnosis Addressing Behavioral Welfare of Dogs and Cats at Home and at the Veterinary Clinic Evidence - Based Approach to Management of Chronic Kidney Disease Diagnosis and Management of Feline Hyperthyroidism The Effect of Stress, Fear, and Anxiety on Behavioral Health and Welfare Diagnosis and Management of Feline Diabetes Diagnostic Approach to Lameness MRSA in the Veterinary Environment Canine and Feline Demodicosis Understanding and Working with Reactivity in Dogs Feline Friendly Handling

A concurrent overall health evaluation includes a thorough physical exam (some dogs can have multiple skin tumors at the time of diagnosis), bloodwork, and urinalysis.

We are starting 2013 with Gambler, a 9 year old neutered male Australian Cattle dog, who was presented to our Oncology department at VRCC in early April 2011, with a biopsy confirmed diagnosis of an plasma cell tumor of the right lower jaw.

Up to 90 % of these tumors will have metastasized or spread to the lungs at the time of diagnosis, but because of the small initial size of the metastatic lesions, less than 10 % will initially show up on a chest x-ray.

Surgical treatment to remove the tumors is the optimal therapy and the largest reported series of cases to date demonstrated a mean survival time after surgery of around 500 days, which is relatively long given that affected ferrets are usually middle - aged at the time of diagnosis.

Finally, Hannibal's tumor sample made it to Breen's lab at NC State, where a genomic test and pathology report confirmed a diagnosis of T cell lymphoma.

Conventional treatment for skin cancer depends on the type of tumor and how advanced the disease is at the time of diagnosis.

An aggressive tumor that rapidly spreads throughout the body (in most cases, at the time of diagnosis, the cancer has already spread beyond the primary tumor)

Grade III tumors treated with surgery alone had no survivors at one year from the time of diagnosis.

Because of their location, oral malignant tumors are often detected late in the course of the disease process and have commonly progressed to Stage II at the time of diagnosis.

Less than 5 % of dogs with long bone tumors have radiographically detectable metastasis to the lungs at the time of diagnosis.

In some cases, the diagnosis can be confirmed via biopsy of the tumor (at surgery or with a small biopsy done through the chest wall using a scope)..

Even if the tumor has spread at the time of diagnosis and surgery, a permanent cure is rare, and the tumor can recur.

She was presented to our Oncology department at VRCC in May of 2009, with a biopsy confirmed diagnosis of an aggressive sweat gland tumor (anaplastic apocrine gland adenocarcinoma) of the skin of the right chest wall.

Treatment depends on the location of the tumor and whether there has been metastasis at the time of diagnosis.

Osteosarcoma is a very aggressive and rapidly spreading tumor with even microscopic (not visible to the naked eye) spread assumed at the time of diagnosis.

A high number, 40 to 50 percent, of these tumors are malignant, meaning they have spread to other locations — primarily the lungs or lymph nodes — at the time of diagnosis.

The purpose of our study was to determine if specific host factors, such as age at diagnosis, obesity, and hormone status, influence the prognosis of canine mammary gland carcinomas and to confirm if previously reported risk factors (ie, histologic subtype, tumor size, and World Health Organization [WHO] stage) were important in a large series of affected dogs.

Patients whose tumors had mutations in three genes and lived at least 10 years after diagnosis, while more than 60 percent of patients whose tumors lacked these mutations died within five years of diagnosis.

Publications Awarded first prize for abstract presentation at AACE meeting in San Diego, CA, May 2003 Young Investigator Award at San Diego at the AACE meeting, May 2003 Diagnosis of Ectopic ACTH secreting tumor by Octreatide scan, presented at the AACE, San Diego, CA, May 2003 Effect of Gludopa on Phosphate Excretion, J Lab and Clinical Medicine, Jan., 2000, vol 135, 51 - 56.